1. Home
  2. LFVN vs GRML Comparison

LFVN vs GRML Comparison

Compare LFVN & GRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$5.17

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

GRML

Greenland Mines Ltd. Common Stock

N/A

Current Price

$0.36

Market Cap

51.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LFVN
GRML
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
5
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.5M
51.5M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
LFVN
GRML
Price
$5.17
$0.36
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
227.7K
2.9M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
3.56%
N/A
EPS Growth
226.09
N/A
EPS
0.30
N/A
Revenue
$203,204,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.23
N/A
Revenue Growth
1.86
N/A
52 Week Low
$3.90
$0.27
52 Week High
$15.00
$0.55

Technical Indicators

Market Signals
Indicator
LFVN
GRML
Relative Strength Index (RSI) 51.44 38.33
Support Level $4.21 $0.31
Resistance Level $5.37 $0.43
Average True Range (ATR) 0.40 0.05
MACD -0.04 -0.02
Stochastic Oscillator 36.05 7.82

Price Performance

Historical Comparison
LFVN
GRML

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About GRML Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Share on Social Networks: